Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Autoimmune Diseases
>>
Immunotherapy
>>
Phase 4
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
15
30
45
60
75
90
105
120
135
150
Rituxan
(rituximab) / Roche
Humira
(adalimumab) / AbbVie
Enbrel
(etanercept) / Pfizer, Amgen
Orencia
(abatacept) / BMS
glatiramer acetate
/ Generic mfg.
Remicade
(infliximab) / J&J
Cimzia
(certolizumab pegol) / Astellas, UCB
tacrolimus intravenous
/ Generic mfg.
Simponi
(golimumab) / Merck (MSD), Mitsubishi Tanabe, J&J
teriflunomide
/ Generic mfg.
sulfasalazine
/ Generic mfg.
Campath
(alemtuzumab) / Sanofi
Lemtrada
(alemtuzumab) / Sanofi
Privigen
(human immune globulin intravenous 10%) / CSL Behring
interferon alpha-2b Paradigm pump infusion system
/ Medtronic
Prolia
(denosumab) / Amgen
Careram
(iguratimod) / Eisai, R-Pharm
Lexiscan
(regadenoson) / GE Healthcare, Astellas, Gilead
thalidomide
/ Generic mfg.
